|
1
|
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies.
|
Lancet
|
2010
|
11.55
|
|
2
|
Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies.
|
Am J Epidemiol
|
1999
|
6.42
|
|
3
|
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.
|
JAMA
|
2005
|
5.60
|
|
4
|
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases.
|
Eur J Epidemiol
|
2007
|
3.81
|
|
5
|
Chlamydia pneumoniae IgA titres and coronary heart disease; prospective study and meta-analysis.
|
Eur Heart J
|
2002
|
3.09
|
|
6
|
Associations of plasma fibrinogen levels with established cardiovascular disease risk factors, inflammatory markers, and other characteristics: individual participant meta-analysis of 154,211 adults in 31 prospective studies: the fibrinogen studies collaboration.
|
Am J Epidemiol
|
2007
|
2.13
|
|
7
|
Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies.
|
J Thromb Haemost
|
2005
|
1.99
|
|
8
|
Plasma homocysteine and coronary heart disease: systematic review of published epidemiological studies.
|
J Cardiovasc Risk
|
1998
|
1.43
|
|
9
|
Underestimation of the importance of blood pressure and cholesterol for coronary heart disease mortality in old age.
|
Eur Heart J
|
2002
|
1.41
|
|
10
|
The importance of cholesterol, blood pressure and smoking for coronary heart disease.
|
Eur Heart J
|
2003
|
1.38
|
|
11
|
Systematically missing confounders in individual participant data meta-analysis of observational cohort studies.
|
Stat Med
|
2009
|
1.27
|
|
12
|
Tissue plasminogen activator antigen and coronary heart disease. Prospective study and meta-analysis.
|
Eur Heart J
|
2004
|
1.24
|
|
13
|
Underestimation of the importance of homocysteine as a risk factor for cardiovascular disease in epidemiological studies.
|
J Cardiovasc Risk
|
2001
|
1.17
|
|
14
|
Homocysteine-lowering trials for prevention of vascular disease: protocol for a collaborative meta-analysis.
|
Clin Chem Lab Med
|
2007
|
0.85
|
|
15
|
WITHDRAWN: Tacrine for Alzheimer's disease.
|
Cochrane Database Syst Rev
|
2007
|
0.81
|
|
16
|
Tacrine for Alzheimer's disease.
|
Cochrane Database Syst Rev
|
2000
|
0.78
|
|
17
|
Tacrine for Alzheimer's disease.
|
Cochrane Database Syst Rev
|
2000
|
0.75
|